Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-CRM and MMRV vaccine in healthy toddlers
NCT00626327Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2008
- Primary completion
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Meningococcal A, C, Y and W-135 conjugate vaccine in meningococcal infection, measles, mumps, rubella, varicella (VZV), sponsored by Novartis. Started Feb 2008; status: completed.
02
Drugs
Meningococcal A, C, Y and W-135 conjugate vaccine
03
Conditions
meningococcal infectionmeaslesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00626327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626327.